Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AtriCure (ATRC) EBT (2016 - 2025)

Historic EBT for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to -$86000.0.

  • AtriCure's EBT rose 9885.81% to -$86000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$27.8 million, marking a year-over-year increase of 2636.55%. This contributed to the annual value of -$43.7 million for FY2024, which is 4632.63% down from last year.
  • AtriCure's EBT amounted to -$86000.0 in Q3 2025, which was up 9885.81% from -$5.9 million recorded in Q2 2025.
  • AtriCure's 5-year EBT high stood at $97.1 million for Q3 2021, and its period low was -$16.9 million during Q1 2021.
  • Over the past 5 years, AtriCure's median EBT value was -$9.0 million (recorded in 2023), while the average stood at -$4.3 million.
  • Its EBT has fluctuated over the past 5 years, first soared by 206135.68% in 2021, then crashed by 13255.12% in 2023.
  • Quarter analysis of 5 years shows AtriCure's EBT stood at -$13.7 million in 2021, then surged by 70.42% to -$4.0 million in 2022, then crashed by 132.55% to -$9.4 million in 2023, then crashed by 62.51% to -$15.3 million in 2024, then soared by 99.44% to -$86000.0 in 2025.
  • Its EBT was -$86000.0 in Q3 2025, compared to -$5.9 million in Q2 2025 and -$6.5 million in Q1 2025.